ClinicalTrials.Veeva

Menu

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population (BrCa)

L

Liaquat University of Medical & Health Sciences

Status

Enrolling

Conditions

Breast Cancer
Treatment
Molecular Pathway Deregulation

Treatments

Procedure: Molecular characterisation

Study type

Observational

Funder types

Other

Identifiers

NCT06830590
BreastCa001

Details and patient eligibility

About

This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC

Enrollment

300 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women with confirmed diagnosis of breast cancer without history of taking neoadjuvant therapy Good quality tumour samples available for IHC

Exclusion criteria

  • patients received pre-operative chemotherapy or radiotherapy

Trial design

300 participants in 1 patient group

Early operable primary breast cancer
Description:
1. women 2. any age group 3. confirmed diagnosis of breast cancer
Treatment:
Procedure: Molecular characterisation

Trial contacts and locations

1

Loading...

Central trial contact

Binafsha Manzoor M Syed, MBBS, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems